Jin Medical International (ZJYL) Receivables (2022 - 2025)

Jin Medical International (ZJYL) has reported Receivables for 4 consecutive years, with $6.1 million the latest figure, recorded in Q3 2025.

• Quarterly Receivables fell 1.01% year-over-year to $6.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.1 million (down 1.01% YoY) and the FY2025 annual result came in at $20.2 million, up 7.01% from the prior year.
• Receivables retreated to $6.1 million in Q3 2025 per ZJYL's latest filing, from $16.9 million in the prior quarter.
• Over the last five years, Receivables for ZJYL reached as high as $16.9 million in Q1 2025 and fell as low as $3.3 million in Q1 2024.
• A 4-year average of $8.1 million and a median of $6.2 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2024 — Receivables tumbled 61.96% — and 2025, when it jumped 409.03%.
• Year by year, Receivables stood at $4.0 million in 2022, then jumped by 180.7% to $11.1 million in 2023, then sank by 44.48% to $6.2 million in 2024, then fell by 1.01% to $6.1 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $6.1 million, $16.9 million, and $6.2 million for Q3 2025, Q1 2025, and Q3 2024 respectively.